Skyscape's iPhone App Proves to be Popular

Article

Over 100,000 healthcare professionals have downloaded Skyscape's iPhone application. Have you?

Over 100,000 healthcare professionals have downloaded Skyscape's iPhone application. Have you?

One great aspect about the iPhone is its ability to run applications. Many healthcare app developers have created iPhone-specific versions of their software so it can be used by medical professionals wherever they happen to be. Skyscape is one such company.

Skyscape's software includes a portfolio providing access to drug information, drug interactions, clinical and evidence-based information, and guidelines. It also offers its MedAlert service, which provides medical news, research and clinical trials updates, and journal summaries by specialty.

The software is a hit. Andrew Schuman, MD, a practicing pediatrician, said, "My needs for the clinical information are met with Skyscape's specialty specific portfolio that goes well beyond the drug information offered by others. I can truly rely on Skyscape's trusted decision support resources at the point of care." Schuman is also contributing editor of Contemporary Pediatrics, and Adjunct Assistant Professor of Pediatrics, Dartmouth Medical School, Hanover, NH.

According to Sandeep Shah, Skyscape's president and CEO, downloads of the free software doubled during the fourth quarter, reaching 8,000 downloads per day. Skyscape isn't the only iPhone-specific software out there.

Hundreds of applications are available via the iTunes Apps Store. Do you use your mobile phone for your practice? If so, what software are you using and for what purpose?

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.